Core Viewpoint - A class action lawsuit has been filed against Plug Power Inc. and certain senior executives for securities fraud following significant stock drops attributed to potential violations of federal securities laws [1][3]. Company Overview - Plug Power provides hydrogen fuel cell turnkey solutions for electric mobility and stationary power markets and develops infrastructure such as hydrogen production plants [4]. Legal Proceedings - Investors have until April 3, 2026, to request to lead the case in the U.S. District Court for the Northern District of New York, under the case caption Ortolani v. Plug Power Inc., et al., No. 1:26-cv-00165 [3]. Allegations - The lawsuit claims that Plug Power materially overstated the likelihood of receiving a $1.66 billion loan guarantee from the U.S. Department of Energy, which was intended to finance the construction of hydrogen production facilities [4]. Stock Performance - On October 7, 2025, Plug Power's stock dropped by $0.26 per share (6.3%) following the announcement of the abrupt departure of its CEO and President [5]. - On November 10, 2025, the stock fell by $0.09 per share (3.4%) after the company suspended activities under the DOE loan program [6]. - A further drop of $0.48 per share (17.6%) occurred on November 14, 2025, after reports confirmed the suspension of plans to construct hydrogen production facilities, jeopardizing the $1.66 billion DOE loan [7].

Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. and its senior executives for securities fraud following a significant stock drop attributed to potential violations of federal securities laws [1][3]. Company Overview - Ardent Health, Inc. operates acute care hospitals and other healthcare facilities, with a focus on the collection of accounts receivable [4]. Allegations of Fraud - The lawsuit claims that Ardent Health misrepresented its process for determining the collectability of accounts receivable, stating it relied on "detailed reviews of historical collections," while in reality, it used a "180-day cliff" method to reserve accounts, leading to inflated receivable reports [4]. Stock Performance Impact - On November 12, 2025, Ardent Health disclosed a $43 million revenue decrease for the quarter and increased its professional liability reserves by $54 million, resulting in a stock price drop of $4.75 per share, or over 33%, from $14.05 to $9.30 [5]. Legal Proceedings - Investors have until March 9, 2026, to request to lead the case in the U.S. District Court for the Middle District of Tennessee, under the caption Postiwala v. Ardent Health, Inc., et al. [3].

New York, New York--(Newsfile Corp. - February 18, 2026) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Kyndryl Holdings, Inc. (NYSE: KD) and certain of the Company's senior executives for securities fraud after significant stock drops resulting from the potential violations of the federal securities laws. If you invested in Kyndryl, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/kyndryl-ho ...

Core Viewpoint - Hub Group Inc. is under investigation for potential violations of federal securities laws, specifically regarding misrepresentation of transportation costs and accounts payable for the first nine months of 2025 [2][3]. Company Overview - Hub Group is a major supply chain solutions provider in North America, specializing in transportation and logistics management services [2]. Investigation Details - The investigation by Bleichmar Fonti & Auld LLP focuses on whether Hub Group misrepresented its financial data, particularly concerning purchased transportation costs and accounts payable [2]. - The firm is encouraging investors to seek additional information regarding their legal options [5]. Stock Performance - Following the announcement of a delay in the release of its fourth quarter and full year 2025 financial results, Hub Group's stock price fell over 24% on February 6, 2026 [3][4]. - The delay is attributed to an error that understated purchased transportation costs and accounts payable, with no estimate provided for the financial impact or a timeline for restatement [3].

Core Viewpoint - The PayPal class action lawsuit alleges that the company and certain executives misled investors regarding the company's revenue outlook and growth potential during the Class Period from February 25, 2025, to February 2, 2026 [1][3]. Group 1: Lawsuit Details - The lawsuit, titled Goodman v. PayPal Holdings, Inc., claims violations of the Securities Exchange Act of 1934 by PayPal and its executives [1]. - The class action seeks to represent purchasers or acquirers of PayPal common stock during the specified Class Period [1][2]. - Allegations include creating a false impression of reliable revenue projections and downplaying risks associated with seasonality and macroeconomic factors [3]. Group 2: Financial Performance - On February 3, 2026, PayPal announced disappointing financial results for Q4 and the full fiscal year 2025, which included a decline in Branded Checkout performance and the withdrawal of previously set 2027 financial targets [4]. - The company attributed its poor performance and lowered guidance to macroeconomic factors, competition, and operational issues across all regions [4]. - Following the announcement, PayPal's stock price reportedly fell by more than 20% [4]. Group 3: Lead Plaintiff Process - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased PayPal common stock during the Class Period to seek appointment as lead plaintiff in the lawsuit [5]. - The lead plaintiff represents the interests of all class members and can select a law firm to litigate the case [5]. Group 4: Law Firm Background - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder rights litigation, having recovered over $916 million for investors in 2025 alone [6]. - The firm has a strong track record, recovering a total of $8.4 billion for investors over the past five years, significantly more than any other law firm [6].

Core Viewpoint - The Enphase Energy class action lawsuit alleges that the company and its executives made misleading statements regarding their financial and operational capabilities, leading to significant stock price declines following the disclosure of poor financial results [1][3][4]. Group 1: Lawsuit Details - The class action lawsuit seeks to represent purchasers of Enphase Energy securities from April 22, 2025, to October 28, 2025 [1]. - The lawsuit is titled Tripathi v. Enphase Energy, Inc., and is filed in the Northern District of California [1]. - Allegations include overstating the company's ability to manage channel inventory and mitigate the impact of the termination of the Residential Clean Energy Credit [3]. Group 2: Financial Impact - On October 28, 2025, Enphase Energy reported third-quarter financial results, indicating that elevated channel inventory would lead to lower battery storage shipments in the fourth quarter of 2025 [4]. - The expiration of the 25D Credit is expected to negatively impact revenues for the first quarter of 2026 [4]. - Following the announcement, Enphase Energy's stock price fell by more than 15% [4]. Group 3: Lead Plaintiff Process - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased Enphase Energy securities during the class period to seek appointment as lead plaintiff [5]. - The lead plaintiff represents the interests of all class members and can select a law firm for litigation [5]. - Participation as a lead plaintiff does not affect an investor's ability to share in any potential recovery [5]. Group 4: Law Firm Background - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder rights litigation, having recovered over $916 million for investors in 2025 [6]. - The firm has ranked 1 in securities class action recoveries for four out of the last five years, totaling $8.4 billion in recoveries during that period [6].

Core Viewpoint - Pomerantz LLP is investigating claims of potential securities fraud or unlawful business practices involving ImmunityBio, Inc. and its officers or directors [1]. Group 1: Company Overview - ImmunityBio, Inc. is listed on NASDAQ under the ticker IBRX [1]. - The company recently announced updated Phase 2 clinical results for a chemotherapy-free combination immunotherapy regimen targeting second-line recurrent or progressive glioblastoma [3]. Group 2: Recent Developments - On January 23, 2026, ImmunityBio reported that the median overall survival, a primary endpoint for its clinical trial, has not yet been reached [3]. - Following the announcement of the clinical results, ImmunityBio's stock price decreased by $0.89 per share, representing a 12.13% decline, closing at $6.45 per share [3]. Group 3: Legal Context - Pomerantz LLP is recognized for its expertise in corporate, securities, and antitrust class litigation, having a history of recovering significant damages for victims of securities fraud and corporate misconduct [4].

Core Viewpoint - Pomerantz LLP is investigating potential securities fraud or unlawful business practices by PennyMac Financial Services, Inc. and its officers or directors following disappointing financial results and a significant stock price drop [1][3]. Financial Performance - On January 29, 2026, PennyMac reported disappointing financial results for Q4 2025, indicating challenges in capitalizing on refinance opportunities due to increased competition in the origination market [3]. - Following the earnings report, PennyMac's stock price fell by $49.78 per share, or 33.25%, closing at $99.92 per share on January 30, 2026 [4]. Legal Investigation - Pomerantz LLP is actively investigating claims on behalf of PennyMac investors, suggesting potential securities fraud or other unlawful practices by the company and its leadership [1].

Core Viewpoint - A class action lawsuit has been filed against PayPal Holdings, Inc. for securities fraud, following a significant drop in stock price after a leadership change and disappointing earnings report [1]. Group 1: Lawsuit Details - The class action lawsuit is on behalf of investors who purchased PayPal common stock between February 25, 2025, and February 2, 2026 [1]. - Investors have until April 20, 2026, to file a lead plaintiff motion [1]. - The lawsuit alleges that PayPal made materially false and misleading statements regarding its business operations and prospects during the class period [1]. Group 2: Company Performance - On February 3, 2026, PayPal announced the immediate replacement of CEO Alex Chriss, citing that the pace of change and execution did not meet the Board's expectations [1]. - The company's fourth quarter and full year 2025 earnings report revealed a net revenue increase of only 3% on a currency-neutral basis [1]. - Following the announcement, PayPal's stock price fell by $10.63, or 20.3%, closing at $41.70 per share [1]. Group 3: Allegations Against Defendants - The complaint claims that PayPal overstated its ability to execute on business initiatives and failed to effectively address competition concerns [1]. - It is alleged that the positive statements made by the defendants regarding the company's business were materially misleading and lacked a reasonable basis [1].

Core Viewpoint - Pomerantz LLP is investigating potential securities fraud or unlawful business practices involving Ashford Hospitality Trust, Inc. and its officers or directors [1]. Group 1: Company Actions - On January 13, 2026, Ashford announced the extension of its Highland mortgage loan secured by 18 hotels and suspended preferred dividends to maintain liquidity while evaluating strategic alternatives [3]. - Following the announcement, Ashford's stock price decreased by $0.35 per share, or 8.1%, closing at $3.97 per share on the same day [3]. Group 2: Legal Context - Pomerantz LLP is recognized for its expertise in corporate, securities, and antitrust class litigation, having a long history of fighting for victims of securities fraud and corporate misconduct [4].